Revolution Medicines, Inc. (RVMD) Reports Q1 Loss of $1.13

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q1 EPS of ($1.13), versus ($1.09) reported last year.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• UBS Assumes Interactive Brokers Group (IBKR) at Neutral, 'A Best-in-Class, Yet Fairly Valued Brokerage'
• Morgan Stanley Upgrades Mitsubishi Chemical Holdings (4188:JP) (MTLHY) to Overweight
• Goldman Sachs sees refinery exemptions boosting DK cash flow